A proposed mechanism of resistance to cyclophosphamide and phosphoramide mustard in a Yoshida cell line in vitroMCGOWN, A. T; FOX, B. W.Cancer chemotherapy and pharmacology. 1986, Vol 17, Num 3, pp 223-226, issn 0344-5704Article

Differential cytotoxicity of Combretastatins A1 and A4 in two daunorubicin-resistant P388 cell linesMCGOWN, A. T; FOX, B. W.Cancer chemotherapy and pharmacology. 1990, Vol 26, Num 1, pp 79-81, issn 0344-5704Article

Interaction of the novel agent amphethinile with tubulinMCGOWN, A. T; FOX, B. W.British journal of cancer. 1989, Vol 59, Num 6, pp 865-868, issn 0007-0920Article

The role of metallothionein, glutathione S-transferases and DNA repair in resistance to platinum drugs in a series of L1210 cell lines made resistant to anticancer platinum agentsHRUBISKO, M; MCGOWN, A. T; FOX, B. W et al.Biochemical pharmacology. 1993, Vol 45, Num 1, pp 253-256, issn 0006-2952Article

Development and validation of a sensitive solid-phase extraction and high-performance liquid chromatography assay for the novel antitumour agent CT2584 in human plasmaKHAN, P; ABBAS, S; CHEESEMAN, S et al.Journal of chromatography. B, Biomedical sciences and applications. 1999, Vol 721, Num 2, pp 279-284, issn 1387-2273Article

Glutathione-S-transferase activity and isoenzyme levels measured by two methods in ovarian cancer, and their value as markers of disease outcomeWRIGLEY, E. C; MCGOWN, A. T; BUCKLEY, H et al.British journal of cancer. 1996, Vol 73, Num 6, pp 763-769, issn 0007-0920Article

Collateral sensitivity of a methotrexate-resistant L1210 cell line to the vinca alkaloidsPOPPITT, D. G; MCGOWN, A. T; FOX, B. W et al.Cancer chemotherapy and pharmacology. 1984, Vol 13, Num 1, pp 43-46, issn 0344-5704Article

The effect of ifosfamide and its metabolites on intracellular glutathione levels in vitro and in vivoLIND, M. J; MCGOWN, A. T; HADFIELD, J. A et al.Biochemical pharmacology. 1989, Vol 38, Num 11, pp 1835-1840, issn 0006-2952Article

The effect of vinca alkaloids in enhancing the sensitivity of a methotrexate-resistant (L1210/R7A) line, studied by flow cytometric and chromosome number analysisMCGOWN, A. T; POPPITT, D. G; SWINDELL, R et al.Cancer chemotherapy and pharmacology. 1984, Vol 13, Num 1, pp 47-53, issn 0344-5704Article

Comparative studies of the uptake of daunorubicin in sensitive and resistant P388 cell lines by flow cytometry and biochemical extraction proceduresMCGOWN, A. T; WARD, T. H; FOX, B. W et al.Cancer chemotherapy and pharmacology. 1983, Vol 11, Num 2, pp 113-116, issn 0344-5704Article

Effect of verapamil on daunorubicin accumulation in lymphocytes isolated from patients undergoing chemotherapyMCGOWN, A. T; MURPHY, D; CROWTHER, D et al.Cancer chemotherapy and pharmacology. 1991, Vol 27, Num 5, pp 413-415, issn 0344-5704, 3 p.Article

The interaction of chalcones with tubulinLAWRENCE, N. J; MCGOWN, A. T; DUCKI, S et al.Anti-cancer drug design. 2000, Vol 15, Num 2, pp 135-141, issn 0266-9536Article

Potent antimitotic and cell growth inhibitory properties of substituted chalconesDUCKI, S; FORREST, R; HADFIELD, J. A et al.Bioorganic & medicinal chemistry letters (Print). 1998, Vol 8, Num 9, pp 1051-1056, issn 0960-894XArticle

Synthesis, DNA-cleaving properties and cytotoxicity of intercalating chelidamic acid derivativesSEARCEY, M; MCCLEAN, S; MADDEN, B et al.Anti-cancer drug design. 1998, Vol 13, Num 8, pp 837-855, issn 0266-9536Article

Immunohistochemical detection of mutant p53 protein in epithelial ovarian cancer using polyclonal antibody CMI : correlation with histopathology and clinical featuresRENNINSON, J; BAKER, B. W; MCGOWN, A. T et al.British journal of cancer. 1994, Vol 69, Num 3, pp 609-612, issn 0007-0920Article

Bryostatin 1 induces productive Epstein-Barr virus replication in latently infected cells : implications for use in immunocompromised patientsSTEWART, J. P; MCGOWN, A. T; PRENDIVILLE, J et al.Cancer chemotherapy and pharmacology. 1993, Vol 33, Num 1, pp 89-91, issn 0344-5704Article

Metallothionein expression in epithelial ovarian cancer : effect of chemotherapy and prognostic significanceWRIGLEY, E; VERSPAGET, H. W; JAYSON, G. C et al.Journal of cancer research and clinical oncology. 2000, Vol 126, Num 12, pp 717-721, issn 0171-5216Article

Tubulin as a target for anticancer drugs : Agents which interact with the mitotic spindleJORDAN, A; HADFIELD, J. A; LAWRENCE, N. J et al.Medicinal research reviews (Print). 1998, Vol 18, Num 4, pp 259-296, issn 0198-6325Article

Synthesis and cell growth inhibitory properties of substituted (E)-1-phenylbut-1-en-3-onesDUCKI, S; HADFIELD, J. A; HEPWORTH, L. A et al.Bioorganic & medicinal chemistry letters (Print). 1997, Vol 7, Num 24, pp 3091-3094, issn 0960-894XArticle

Isolation of aurantiamide acetate from Arisaema erubescensDUCKI, S; HADFIELD, J. A; ZHANG, X et al.Planta medica. 1996, Vol 62, Num 3, pp 277-278, issn 0032-0943Article

Metallothionein levels in ovarian tumours before and after chemotherapyMURPHY, D; MCGOWN, A. T; CROWTHER, D et al.British journal of cancer. 1991, Vol 63, Num 5, pp 711-714, issn 0007-0920, 4 p.Article

The use of a fluorescent methotrexate probe to monitor the effects of three vinca alkaloids on a mixed population of parental L1210 and gene-amplified methotrexate-resistant cells by flow cytometryPOPPITT, D. G; MCGOWN, A. T; FOX, B. W et al.Cancer chemotherapy and pharmacology. 1984, Vol 13, Num 1, pp 54-57, issn 0344-5704Article

A phase II trial of bryostatin 1 in patients with non-Hodgkin's lymphomaBLACKHALL, F. H; RANSON, M; RADFORD, J. A et al.British journal of cancer. 2001, Vol 84, Num 4, pp 465-469, issn 0007-0920Article

Positron emission tomography of murine liver metastases and the effects of treatment by combretastatin A-4SHA ZHAO; MOORE, J. V; WALLER, M. L et al.European journal of nuclear medicine. 1999, Vol 26, Num 3, pp 231-238, issn 0340-6997Article

Bryostatin 1-tamoxifen combinations show synergistic effects on the inhibition of growth of P388 cells in vitroMCGOWN, A. T; JAYSON, G; PETTIT, G. R et al.British journal of cancer. 1998, Vol 77, Num 2, pp 216-220, issn 0007-0920Article